Acura Pharmaceuticals Debt to Equity Ratio 2012-2021 | ACUR
Current and historical debt to equity ratio values for Acura Pharmaceuticals (ACUR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Acura Pharmaceuticals debt/equity for the three months ending December 31, 2021 was 0.00.
| Acura Pharmaceuticals Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-12-31 | $0.00B | $0.00B | 3.83 |
| 2021-09-30 | $0.00B | $0.00B | 9.42 |
| 2021-06-30 | $0.00B | $0.00B | 3.96 |
| 2021-03-31 | $0.01B | $-0.01B | -1.31 |
| 2020-12-31 | $0.01B | $-0.01B | -1.30 |
| 2020-09-30 | $0.01B | $-0.01B | -1.39 |
| 2020-06-30 | $0.01B | $-0.01B | -1.51 |
| 2020-03-31 | $0.01B | $-0.01B | -1.38 |
| 2019-12-31 | $0.01B | $-0.01B | -1.54 |
| 2019-09-30 | $0.01B | $-0.01B | -1.50 |
| 2019-06-30 | $0.01B | $-0.01B | -1.48 |
| 2019-03-31 | $0.01B | $0.00B | -1.45 |
| 2018-12-31 | $0.01B | $0.00B | -1.60 |
| 2018-09-30 | $0.01B | $0.00B | -1.62 |
| 2018-06-30 | $0.01B | $0.00B | -2.07 |
| 2018-03-31 | $0.00B | $0.00B | -3.14 |
| 2017-12-31 | $0.01B | $0.00B | -171.52 |
| 2017-09-30 | $0.01B | $0.00B | 3.54 |
| 2017-06-30 | $0.01B | $0.00B | -20.50 |
| 2017-03-31 | $0.01B | $0.00B | 4.17 |
| 2016-12-31 | $0.01B | $0.00B | 5.94 |
| 2016-09-30 | $0.01B | $0.00B | -16.82 |
| 2016-06-30 | $0.01B | $0.00B | 5.24 |
| 2016-03-31 | $0.01B | $0.01B | 2.03 |
| 2015-12-31 | $0.01B | $0.01B | 1.15 |
| 2015-09-30 | $0.01B | $0.01B | 1.17 |
| 2015-06-30 | $0.01B | $0.00B | 2.57 |
| 2015-03-31 | $0.01B | $0.01B | 1.74 |
| 2014-12-31 | $0.01B | $0.01B | 2.17 |
| 2014-09-30 | $0.01B | $0.01B | 1.54 |
| 2014-06-30 | $0.01B | $0.01B | 1.12 |
| 2014-03-31 | $0.01B | $0.01B | 0.84 |
| 2013-12-31 | $0.01B | $0.02B | 0.60 |
| 2013-09-30 | $0.00B | $0.02B | 0.05 |
| 2013-06-30 | $0.00B | $0.02B | 0.05 |
| 2013-03-31 | $0.00B | $0.02B | 0.10 |
| 2012-12-31 | $0.00B | $0.03B | 0.05 |
| 2012-09-30 | $0.00B | $0.03B | 0.02 |
| 2012-06-30 | $0.00B | $0.03B | 0.03 |
| 2012-03-31 | $0.00B | $0.03B | 0.03 |
| 2011-12-31 | $0.00B | $0.04B | 0.01 |
| 2011-09-30 | $0.00B | $0.04B | 0.03 |
| 2011-06-30 | $0.00B | $0.04B | 0.03 |
| 2011-03-31 | $0.00B | $0.02B | 0.04 |
| 2010-12-31 | $0.00B | $0.02B | 0.05 |
| 2010-09-30 | $0.00B | $0.03B | 0.05 |
| 2010-06-30 | $0.00B | $0.03B | 0.06 |
| 2010-03-31 | $0.00B | $0.03B | 0.07 |
| 2009-12-31 | $0.00B | $0.03B | 0.07 |
| 2009-09-30 | $0.00B | $0.03B | 0.09 |
| 2009-06-30 | $0.00B | $0.03B | 0.12 |
| 2009-03-31 | $0.00B | $0.04B | 0.12 |
| 2008-12-31 | $0.01B | $0.04B | 0.16 |
| 2008-09-30 | $0.01B | $0.04B | 0.21 |
| 2008-06-30 | $0.01B | $0.03B | 0.23 |
| 2008-03-31 | $0.01B | $0.03B | 0.50 |
| 2007-12-31 | $0.03B | $0.02B | 1.44 |
| 2007-09-30 | $0.01B | $0.01B | 0.62 |
| 2007-06-30 | $0.02B | $-0.01B | -1.10 |
| 2007-03-31 | $0.02B | $-0.01B | -1.14 |
| 2006-12-31 | $0.04B | $-0.04B | -1.04 |
| 2006-09-30 | $0.01B | $-0.01B | -1.16 |
| 2006-06-30 | $0.01B | $-0.01B | -1.25 |
| 2006-03-31 | $0.01B | $-0.01B | -1.28 |
| 2005-12-31 | $0.01B | $-0.01B | -1.29 |
| 2005-09-30 | $0.01B | $-0.01B | -1.43 |
| 2005-06-30 | $0.01B | $0.00B | -1.81 |
| 2005-03-31 | $0.01B | $0.00B | -2.41 |
| 2004-12-31 | $0.01B | $0.00B | -5.58 |
| 2004-09-30 | $0.01B | $0.00B | 29.95 |
| 2004-06-30 | $0.07B | $-0.05B | -1.20 |
| 2004-03-31 | $0.05B | $-0.04B | -1.30 |
| 2003-12-31 | $0.06B | $-0.05B | -1.13 |
| 2003-09-30 | $0.05B | $-0.04B | -1.32 |
| 2003-06-30 | $0.05B | $-0.03B | -1.35 |
| 2003-03-31 | $0.04B | $-0.02B | -1.61 |
| 2002-12-31 | $0.03B | $-0.01B | -2.58 |
| 2002-09-30 | $0.09B | $-0.08B | -1.13 |
| 2002-06-30 | $0.08B | $-0.07B | -1.14 |
| 2002-03-31 | $0.08B | $-0.07B | -1.16 |
| 2001-12-31 | $0.08B | $-0.07B | -1.17 |
| 2001-09-30 | $0.07B | $-0.06B | -1.20 |
| 2001-06-30 | $0.07B | $-0.06B | -1.19 |
| 2001-03-31 | $0.07B | $-0.05B | -1.32 |
| 2000-12-31 | $0.07B | $-0.05B | -1.29 |
| 2000-09-30 | $0.07B | $-0.05B | -1.38 |
| 2000-06-30 | $0.06B | $-0.05B | -1.38 |
| 2000-03-31 | $0.06B | $-0.05B | -1.36 |
| 1999-12-31 | $0.06B | $-0.04B | -1.30 |
| 1999-09-30 | $0.05B | $-0.04B | -1.36 |
| 1999-06-30 | $0.05B | $-0.04B | -1.47 |
| 1999-03-31 | $0.05B | $-0.03B | -1.42 |
| 1998-12-31 | $0.05B | $-0.03B | -1.57 |
| 1998-09-30 | $0.04B | $-0.03B | -1.57 |
| 1998-06-30 | $0.04B | $-0.02B | -1.83 |
| 1998-03-31 | $0.04B | $-0.02B | -2.03 |
| 1997-12-31 | $0.03B | $-0.02B | -1.39 |
| 1997-09-30 | $0.02B | $-0.01B | -1.63 |
| 1997-06-30 | $0.02B | $-0.01B | -2.05 |
| 1997-03-31 | $0.02B | $-0.01B | -2.29 |
| 1996-12-31 | $0.02B | $-0.01B | -2.69 |
| 1996-09-30 | $0.02B | $0.00B | -4.74 |
| 1996-06-30 | $0.02B | $-0.01B | -4.77 |
| 1996-03-31 | $0.02B | $0.00B | -17.45 |
| 1995-12-31 | $0.02B | $0.00B | -13.25 |
| 1995-09-30 | $0.02B | $0.00B | 5.23 |
| 1995-06-30 | $0.02B | $0.00B | 5.15 |
| 1995-03-31 | $0.02B | $0.00B | 4.05 |
| 1994-12-31 | $0.02B | $0.00B | -30.75 |
| 1994-09-30 | $0.02B | $0.00B | 17.32 |
| 1994-06-30 | $0.02B | $0.00B | 9.46 |
| 1994-03-31 | $0.02B | $0.00B | 5.43 |
| 1993-12-31 | $0.02B | $0.00B | 5.31 |
| 1993-09-30 | $0.02B | $0.01B | 1.89 |
| 1993-06-30 | $0.02B | $0.01B | 1.45 |
| 1993-03-31 | $0.02B | $0.02B | 1.30 |
| 1992-12-31 | $0.02B | $0.01B | 1.32 |
| 1992-09-30 | $0.02B | $0.02B | 1.02 |
| 1992-06-30 | $0.02B | $0.01B | 1.10 |
| 1992-03-31 | $0.01B | $0.01B | 1.04 |
| 1991-12-31 | $0.02B | $0.01B | 1.34 |
| 1991-09-30 | $0.01B | $0.01B | 1.07 |
| 1991-06-30 | $0.01B | $0.01B | 1.11 |
| 1991-03-31 | $0.01B | $0.01B | 1.10 |
| 1990-12-31 | $0.01B | $0.01B | 1.23 |
| 1990-09-30 | $0.01B | $0.01B | 1.09 |
| 1990-06-30 | $0.01B | $0.01B | 1.12 |
| 1990-03-31 | $0.01B | $0.01B | 1.06 |
| 1989-12-31 | $0.01B | $0.01B | 0.94 |
| 1989-09-30 | $0.01B | $0.01B | 0.82 |
| 1989-06-30 | $0.01B | $0.01B | 0.97 |
| 1989-03-31 | $0.01B | $0.01B | 1.03 |
| 1988-12-31 | $0.00B | $0.01B | 0.45 |
| 1988-09-30 | $0.00B | $0.01B | 0.35 |
| 1988-06-30 | $0.00B | $0.01B | 0.47 |
| 1988-03-31 | $0.00B | $0.01B | 0.37 |
| 1987-12-31 | $0.00B | $0.01B | 0.38 |
| 1987-09-30 | $0.00B | $0.01B | 0.26 |
| 1987-06-30 | $0.00B | $0.01B | 0.46 |
| 1987-03-31 | $0.00B | $0.01B | 0.44 |
| 1986-12-31 | $0.00B | $0.01B | 0.31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |